Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBurford Capital Regulatory News (BUR)

Share Price Information for Burford Capital (BUR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,259.00
Bid: 1,250.00
Ask: 1,258.00
Change: 3.00 (0.24%)
Spread: 8.00 (0.64%)
Open: 1,268.00
High: 1,276.00
Low: 1,252.00
Prev. Close: 1,256.00
BUR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Statement re High Court decision on LSE data

15 May 2020 10:30

RNS Number : 0599N
Burford Capital Limited
15 May 2020
 

 

 

15 May 2020

 

 

BURFORD CAPITAL STATEMENT ON HIGH COURT DECISION ON ACCESS TO LSE TRADING DATA

 

Burford Capital Limited ("Burford Capital" or "Burford" or "the Company"), the leading global finance and asset management firm focused on law, today released the following statement concerning the High Court's 104-page decision denying its application to obtain trading data from the London Stock Exchange.

 

Burford has previously recounted its efforts to pursue claims for market manipulation following the August 2019 short attack against its shares. Burford retained a leading expert in the area of market manipulation, Professor Joshua Mitts of Columbia University, who was accepted by the Court as an expert whose work has also been presented to the US Securities and Exchange Commission and in other fora.

 

Unfortunately, the Court, while acknowledging that Professor Mitts had presented expert analysis in which he opined "that market manipulation in the form of spoofing and layering caused an artificial decline in Burford's share price", decided that his conclusions were "speculative". The Court held: "In my judgment, the fully true statement is that it is impossible to determine from the data Prof Mitts reviewed whether any Share Order Events were or may have been manipulative; and any claim that there was market manipulation on 6 or 7 August 2019 by reference to Prof Mitts' data analysis is speculative." Of course, this is the conundrum: Without the trading data sought by Burford, it is impossible to prove market manipulation, which is why Burford brought its application in the first place on the basis of Professor Mitts' extensive expert analyses, which are available on Burford's website.

 

To be clear, the Court did not decide whether or not market manipulation had occurred. That was not its function nor the purpose of the proceeding.

 

The Court also held that even had it not concluded that Professor Mitts' expert evidence was speculative, it still would not have granted relief for a variety of policy reasons, including "a risk of damage to public confidence in the FCA as regulator".

 

Burford's goal in this proceeding was to obtain access to the information needed to assist shareholders in bringing claims for market manipulation, which Burford continues to believe occurred. Without that information, Burford is unfortunately not in a position to advance shareholder claims further. While Burford believes the Court's judgment is flawed as a matter of law and deprives shareholders of redress, there is also a limit to the level of effort that it is sensible and appropriate for Burford to expend, and thus Burford does not intend to appeal the Court's ruling.

 

 

For further information, please contact:

 

Burford Capital Limited

Jim Kilman, Chief Financial Officer

+1 917 985 9840

Robert Bailhache, Head of Investor Relations - email

 

+44 (0)20 3530 2023

Macquarie Capital (Europe) Limited - NOMAD and Joint Broker

+44 (0)20 3037 2000

Jonny Allison

Alex Reynolds

Jefferies International Limited - Joint Broker

+44 (0)20 7029 8000

Graham Davidson

Tony White

Numis Securities Limited - Joint Broker

+44 (0)20 7260 1000

Charlie Farquhar

Jonathan Abbott

 

About Burford Capital

Burford Capital is the leading global finance and asset management firm focused on law. Its businesses include litigation finance and risk management, asset recovery and a wide range of legal finance and advisory activities. Burford is publicly traded on the London Stock Exchange, and it works with law firms and clients around the world from its principal offices in New York, London, Chicago, Washington, Singapore and Sydney.

 

For more information about Burford: www.burfordcapital.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRASFISUIESSEFI
Date   Source Headline
24th May 20227:00 amRNSPurchases of Shares for Employee Compensation Plan
23rd May 20227:00 amRNSPurchases of Shares for Employee Compensation Plan
20th May 20225:38 pmRNSResult of AGM
20th May 20224:17 pmRNSPricing of Early Redemption of Bonds Due 2022
20th May 20227:00 amRNSPurchases of Shares for Employee Compensation Plan
19th May 20227:00 amRNSPurchases of Shares for Employee Compensation Plan
18th May 20228:00 amRNSNotice of Retail Shareholder Call on June 16, 2022
18th May 20227:00 amRNSPurchases of Shares for Employee Compensation Plan
17th May 20227:00 amRNSPurchases of Shares for Employee Compensation Plan
16th May 20227:00 amRNSPurchases of Shares for Employee Compensation Plan
13th May 20227:00 amRNSPurchases of Shares for Employee Compensation Plan
10th May 20228:00 amRNSNotice of Early Redemption of Bonds Due 2022
19th Apr 20227:00 amRNSAccess to Summary Judgment Filings in YPF Cases
13th Apr 20225:39 pmRNSCompleted Share Purchase by Employee Benefit Trust
13th Apr 202212:00 pmRNSNotice of 2022 AGM
12th Apr 20227:00 amRNSClosing of Private Offering of Senior Notes
11th Apr 20227:00 amRNSChristopher A. Halmy Nominated as Board Director
8th Apr 202211:30 amRNSDirector/PDMR Shareholding
7th Apr 20227:05 amRNSPricing and Upsizing of Senior Notes Offering
6th Apr 202211:30 amRNSDirector/PDMR Shareholding
4th Apr 20221:15 pmRNSPrivate Offering of Senior Notes
4th Apr 20227:00 amRNSManagement Team Invest $3 Million in Burford Stock
1st Apr 20225:59 pmRNSIntended Purchases of Ordinary Shares
29th Mar 202212:43 pmRNSAvailability of Annual Report
29th Mar 202212:13 pmRNSFull Year Results 2021
28th Mar 20227:00 amRNS$360m Pre-Settlement Investment Fund Close
15th Mar 202212:00 pmRNSNotice of FY21 Earnings Call Details
4th Mar 202212:00 pmRNSNotice of FY21 Results & Earnings Call
1st Mar 20224:53 pmRNSBurford Capital - $100m Equity Project Commitments
15th Feb 20227:00 amRNSUpdate on 2021 Business Activity & Accounting
8th Feb 20223:10 pmRNSBurford Capital's Affirmative Recovery Research
19th Jan 20224:30 pmRNSTR1 - Notification of Major Holdings
24th Dec 202110:00 amRNSTR1 - Notification of Major Holdings
23rd Dec 20217:00 amRNSStatement concerning non-cash accrual
15th Nov 20213:00 pmRNSSterling FX Rate for 2021 Interim Dividend
3rd Nov 20212:00 pmRNSDirector/PDMR Shareholding
2nd Nov 202111:57 amRNSMaterials for Investor Event
12th Oct 20212:00 pmRNSNotice of Investor Event Registration Details
27th Sep 202111:00 amRNSDirector/PDMR Shareholding
27th Sep 20218:30 amRNSCompleted Share Purchase by Employee Benefit Trust
20th Sep 20218:30 amRNSDirector/PDMR Shareholding
17th Sep 20218:30 amRNSDirector/PDMR Shareholding
16th Sep 20218:30 amRNSIntended Share Purchase by Employee Benefit Trust
16th Sep 20217:00 amRNSCompleted Share Purchase for NED Share Plan
15th Sep 202111:00 amRNSDirector/PDMR Shareholding
15th Sep 20218:30 amRNSIntended Share Purchase for NED Share Plan
9th Sep 202112:12 pmRNSNotice of Investor Event Date
9th Sep 202112:12 pmRNSInterim Results for six months ended 30 June 2021
26th Aug 20213:00 pmRNSNotice of 1H21 Results Call Registration Details
23rd Aug 20217:00 amRNSBusiness Performance Update and US GAAP Conversion

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.